## WHO Clinical Staging and ART Initiation This patient requires classification by **WHO clinical stage** and assessment of **CD4 count** to guide ART initiation. ### WHO Clinical Staging (Simplified) | Stage | Clinical Features | CD4 Threshold | ART Indication | |-------|-------------------|---------------|----------------| | **Stage 1** | Asymptomatic or PGL | Any CD4 | CD4 <350 or symptomatic | | **Stage 2** | Mild mucocutaneous disease (oral candidiasis, seborrheic dermatitis, recurrent herpes) | Any CD4 | **Initiate immediately** | | **Stage 3** | Advanced mucocutaneous + systemic (TB, pneumonia, diarrhea >1 month) | Any CD4 | Initiate immediately | | **Stage 4** | AIDS-defining (PCP, toxoplasmosis, CMV, cryptococcal meningitis, MAC) | <50 | Initiate immediately + OI prophylaxis | ### This Patient's Classification **Key Point:** Oral candidiasis = **WHO Stage 2** (mild mucocutaneous disease) - **Clinical stage:** Stage 2 (oral candidiasis) - **CD4 count:** 320 cells/μL - **Serostatus:** Confirmed HIV-1 positive - **Prior ART:** None ### ART Initiation Criteria (Current WHO/India Guidelines) **High-Yield:** According to **2023 WHO consolidated guidelines** and **NACO (National AIDS Control Organization) India guidelines**: 1. **All patients with CD4 <350 cells/μL** → Initiate ART immediately 2. **All patients with WHO Stage 2 or higher** → Initiate ART immediately (regardless of CD4) 3. **Asymptomatic with CD4 >350** → Can defer, but early initiation is now preferred ### Why This Patient Gets ART Now **Clinical Pearl:** This patient meets **TWO criteria** for immediate ART: 1. CD4 = 320 cells/μL (below 350 threshold) 2. WHO Stage 2 (oral candidiasis = symptomatic disease) → **Initiate ART immediately** (e.g., TDF/3TC/EFV or TAF/3TC/DTG) ### Treatment of Oral Candidiasis - **First-line:** Fluconazole 200 mg daily × 7–14 days - **Prophylaxis:** If CD4 <50 cells/μL, consider fluconazole 100 mg daily - **Note:** Candidiasis usually resolves within 2–4 weeks of ART initiation ### Mnemonic for ART Initiation Triggers **STAGE 2 or CD4 <350 = START ART** - **S** = Symptomatic (Stage 2–4) - **T** = TB or other OI - **A** = Any Stage 3–4 disease - **R** = Recent diagnosis (all patients now) - **T** = Treat early (current paradigm) - **E** = Every patient with CD4 <350 [cite:NACO India ART Guidelines 2023; WHO Consolidated Guidelines 2023]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.